log in
Print | Back

Haynes and Boone

Suzanne A. Trigg

Suzanne A. Trigg



  • Advertising, Marketing, and Promotional Law
  • FDA - Medical Device, Food and Cosmetics
  • Food, Beverage and Restaurant
  • Franchise and Distribution

WSG Practice Industries


Haynes and Boone
Texas, U.S.A.

WSG Leadership

WSG Coronavirus Task Force Group
Suzie Trigg guides companies through FDA regulatory matters, high-stakes supply chain transactions, and strategic growth. She leverages her unique experience to help companies negotiate and document transactions and make well-informed decisions to address their complex FDA regulatory requirements. She holds leadership positions in the firm's Healthcare and Life Sciences Practice Group, and its Food, Beverage and Restaurant Practice Group.

Suzie is a go-to lawyer for companies tackling critical supply chain challenges, having been lead outside counsel for, among others, a 7,500+ store retailer negotiating supply chain agreements for transactions valued at more than $25 billion over five years. Her recent work also includes:

Facilitating investigations and analyses of high-stakes food safety and other product concerns, including both preventive gap analyses and analyzing specific events to determine FDA regulatory obligations and to chart a long-term course of action to correct and prevent re-occurrence of the potential concerns

Preparing and implementing supplier standards and supply chain agreements for multiple global restaurant chains

Developing and negotiating commercial agreements and quality agreements for the manufacture, supply, and distribution of both branded and private label foods, cosmetics, dietary supplements, and over-the-counter drugs

Suzie helps companies lawfully market their products by reviewing the use of specific ingredients and by reviewing product claims made on labels or in advertising. Her experience in this area includes foods, dietary supplements, cosmetics, personal care products, and over-the-counter drugs. She frequently provides advice and guidance on strategies intended to reduce the risk of a demand, class action, or regulatory enforcement.

While much of her work focuses on designing strategies to minimize risk and avoid costly delays or setbacks, Suzie also helps companies thoroughly and efficiently address obstacles, such as potential FDA enforcement actions, potential product recalls, and disputes with distributors or other supply chain partners.

Given Suzie's experience, she often leads due diligence of FDA regulated companies in connection with a potential merger or acquisition and addresses issues critical to deal closure. Suzie has also conducted due diligence for potential underwriters of securities offerings by emerging pharmaceutical, medical device, and biologic companies.

Suzie is in her third year of serving on FDLI's Food Advertising and Litigation Conference Planning Committee. She previously served on FDLI's Food and Dietary Supplements Committee and FDLI's Writing Awards Committee.

Bar Admissions

Texas, 2006


J.D., University of Texas at Austin School of Law, 2006, with honors, Texas Environmental Law Journal
B.S., Animal Science, Texas A&M University, 2003
Areas of Practice

Advertising, Marketing, and Promotional Law | FDA - Medical Device, Food and Cosmetics | Food, Beverage and Restaurant | Franchise and Distribution | Government and Public Policy | Government Relations | Life Sciences | Supply Chain Management


FDA Increase Supplies in Response to COVID-19
Haynes and Boone, March 2020

FDA Takes Action to Increase U.S. Supplies in Response to COVID-19. The FDA took action to increase U.S. supplies to support the U.S. response to COVID-19 by providing instructions to manufacturers importing personal protective equipment and other devices. The FDA is engaging the import trade community during this pandemic to facilitate the entry of needed products, including PPE, into the U.S...

FDA Warns Consumers About Unauthorized Fraudulent COVID19 Products
Haynes and Boone, March 2020

FDA Warns Consumers About Unauthorized Fraudulent COVID-19 Products.The FDA issued a Consumer Update advising consumers to be beware of fraudulent coronavirus tests, vaccines and treatments. The FDA has seen unauthorized fraudulent test kits for COVID-19 being sold online. Currently, the FDA has not authorized any test that is available to purchase for testing yourself at home for COVID-19...

FDA Revised Guidance on Postmarketing Adverse Event Reporting for Medical Products and Dietary Supplements During a Pandemic
Haynes and Boone, March 2020

The FDA revised its guidance on postmarket adverse event reporting for medical products and dietary supplements during a pandemic to apply the guidance to the ongoing COVID-19 pandemic. The FDA acknowledges that companies, and the agency, itself, may be hit with workforce shortages during a pandemic at the same time that adverse event reporting for products deployed for the pandemic may increase...


Haynes and Boone Blogs
Haynes and Boone 

Haynes and Boone Blogs includes the Firm Blog, IP Beacon: Patent Law Review, Practical Benefits Lawyer, Texas Insurance Academy and The Dec Sheet-Insurance Law

WSG's members are independent firms and are not affiliated in the joint practice of professional services. Each member exercises its own individual judgments on all client matters.

HOME | SITE MAP | GLANCE | PRIVACY POLICY | DISCLAIMER |  © World Services Group, 2021